Hatteras Venture Partners Iv Sbic, Lp - Net Worth and Insider Trading

Hatteras Venture Partners Iv Sbic, Lp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Hatteras Venture Partners Iv Sbic, Lp owns 2 companies in total, including G1 Therapeutics Inc (GTHX) , and Clearside Biomedical Inc (CLSD) .

Click here to see the complete history of Hatteras Venture Partners Iv Sbic, Lp’s form 4 insider trades.

Insider Ownership Summary of Hatteras Venture Partners Iv Sbic, Lp

Ticker Comapny Transaction Date Type of Owner
GTHX G1 Therapeutics Inc 2017-05-22 10 percent owner
CLSD Clearside Biomedical Inc 2016-06-01 10 percent owner

Hatteras Venture Partners Iv Sbic, Lp Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Hatteras Venture Partners Iv Sbic, Lp Ownership Network

Ownership Network List of Hatteras Venture Partners Iv Sbic, Lp

No Data

Ownership Network Relation of Hatteras Venture Partners Iv Sbic, Lp

Insider Network Chart

Hatteras Venture Partners Iv Sbic, Lp Owned Company Details

What does G1 Therapeutics Inc do?

Who are the key executives at G1 Therapeutics Inc?

Hatteras Venture Partners Iv Sbic, Lp is the 10 percent owner of G1 Therapeutics Inc. Other key executives at G1 Therapeutics Inc include Chief Financial Officer John V. Umstead , Chief Commercial Officer Andrew Perry , and Chief Business Officer Mark Avagliano .

G1 Therapeutics Inc (GTHX) Insider Trades Summary

Over the past 18 months, Hatteras Venture Partners Iv Sbic, Lp made no insider transaction in G1 Therapeutics Inc (GTHX). Other recent insider transactions involving G1 Therapeutics Inc (GTHX) include a net sale of 78,166 shares made by Rajesh Malik , a net sale of 92,308 shares made by Bailey John E. (jack) Jr. , and a net sale of 15,968 shares made by John V. Umstead .

In summary, during the past 3 months, insiders sold 17,114 shares of G1 Therapeutics Inc (GTHX) in total and bought 0 shares, with a net sale of 17,114 shares. During the past 18 months, 295,121 shares of G1 Therapeutics Inc (GTHX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 295,121 shares.

G1 Therapeutics Inc (GTHX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

G1 Therapeutics Inc Insider Transactions

No Available Data

Hatteras Venture Partners Iv Sbic, Lp Mailing Address

Above is the net worth, insider trading, and ownership report for Hatteras Venture Partners Iv Sbic, Lp. You might contact Hatteras Venture Partners Iv Sbic, Lp via mailing address: 280 S. Mangum Street, Suite 350, Durham Nc 27701.

Discussions on Hatteras Venture Partners Iv Sbic, Lp

No discussions yet.